In India, the Attempt has been causing a stir,dasCorona to want to MedikamentCovaxinin an incredibly short period of time.BalramBhargava, the Director of the Indian Council for medical research (ICMR) had announced in a public that has become letter,denImpfstoff from the 7. To July of this year, people test it on 15. To bring August on the market.
Christoph Hein
Economics correspondent for South Asia/Pacific, based in Singapore.
F. A. Z.
The vaccine will be jointly undBharatBiotechentwickelt of ICMR. He is considered one of the vaccines, the global potential is said. However, it usually takes years for the clinical Tests complete: In the case of Ebola, about nThe Tests ongoing since 1998, in the case of Dengue Fiebervon 1945 to 2019.
“It is impossible”
With a view to Corona, however, the test speed around the earth. Currently, there are around the world 15 vaccines in late-stage development, eight of them by Chinese companies. Only a drug of AstraZenecaund of Oxford University, had 20 up to. June phase 3 of the Tests achieved.
The vonBhargavageforderteGeschwindigkeit head shaking and criticism received.KiranMazumdarShaw,the founder and Boss of India’s Biotech company, BIOCON said simply: “It is impossible for the phases 1 to 3 of a Covid-19-vaccination in the six weeks to complete.”
300 million doses
Krishna Ella, CEO of Bharat biotech, said to the Agency Reuters, the company plan in the year up to 300 million doses of the vaccine to produce if clinical trials were successful.In the Indian remote he said see: “This vaccine will definitely be until December, when the authorities will help us.” It slopes to the regulatory authorities: “Many countries take the shortcut. If Phase one and two are successful, can authorise the authorities to make the vaccine in the market.“
He stressed that the release of other vaccines did, in fact, lasted from twelve to sixteen years. For the first two PhasenvonCovaxinsuche biotech Bharat currently have 1200 Volunteers.Starting this Monday, the vaccine should be tested in twelve hospitals.